Advanced Ovarian Cancer Treatment
Links shared publicly online about this topic
Treatment for Advanced Ovarian Cancer Effective
disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancer” View full resource at disabled-world.com
Most Recently Shared on June 6, 2010 at 11:31 pm By:
Disabled World Health Advocate and Health News
Treatment for Advanced Ovarian Cancer Effective http://ff.im/-lA8Uw
Personalized treatment for ovarian cancer
sciencedaily.com — “Researchers have shown that point mutations -- misspellings in a single letter of genetic code -- that drive the onset and growth of cancer cells can be detected successfully in advanced ovarian cancer using a technique called OncoMap. The finding opens the way for personalized medicine.” View full resource at sciencedaily.com
Most Recently Shared on November 18, 2010 at 2:22 pm By:
Personalized treatment for ovarian cancer: Researchers have shown that point mutations -- misspellings in a sing... http://bit.ly/brua4r
Phase 2 study of aflibercept for the treatment of advanced ovarian cancer with ascites - MPR
empr.com — “Sanofi-aventis and Regeneron Pharmaceuticals announced data from a Phase 2 trial for their fusion protein product, aflibercept (VEGF Trap), in the treatment of advanced ovarian cancer patients with recurrent symptomatic malignant ascites (SMA).” View full resource at empr.com
Most Recently Shared on June 11, 2009 at 6:34 pm By:
MPR News: Phase 2 study of aflibercept for the treatment of advanced ovarian cancer with ascites: Sanof.. http://tinyurl.com/mobhuq
New treatment regimen shown effective against advanced ovarian cancer
physorg.com — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment ...” View full resource at physorg.com
Most Recently Shared on June 6, 2010 at 4:50 pm By:
PhysOrg Health News Health News
New treatment regimen shown effective against advanced ovarian cancer http://tw.physorg.com/195047400
New treatment regimen shown effective against advanced ovarian cancer
eurekalert.org — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at eurekalert.org
Most Recently Shared on June 6, 2010 at 6:53 pm By:
New treatment regimen shown effective against advanced ovarian cancer: (Fox Chase Cancer Center) Newly reported re... http://bit.ly/a8Fohc
Key advances in ovarian cancer (ASCO 2010 ) Video
vodpod.com — “Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses research demonstrating the effectiveness of combining bevacizumab with chemotherapy as first line treatment of ovarian cancer. A second key presentation was research indicating that PARP inhibitors are effective at treating not just ovarian cancer caused by BRCA mutation but also high grade serous cancer. If this result is confirmed in further studies, it wo” View full resource at vodpod.com
Most Recently Shared on July 22, 2010 at 9:59 pm By:
Paul Cacciatore Patient Advocate
Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun
Studies Examine Treatment Options For Ovarian Cancer Patients
medicalnewstoday.com — “Long-term use of the cancer medication Avastin may help women with ovarian cancer live longer without their cancer progressing, new research shows. Experimental drug NKTR-102 produced substantial” View full resource at medicalnewstoday.com
Most Recently Shared on June 8, 2010 at 2:06 pm By:
MNT Ovarian Cancer Health News
Studies Examine Treatment Options For Ovarian Cancer Patients http://mnt.to/3DCJ #ovariancancer
Stopping Ovarian Cancer
health.com — “Cutting-edge advances are transforming ovarian cancer from a death sentence into a disease women can beat. See how the detection and treatment breakthroughs that are already saving lives.” View full resource at health.com
Most Recently Shared on August 19, 2011 at 1:35 pm By:
Health magazine Health Magazine
Transforming #ovarian #cancer from a death sentence into a disease women can beat. Read on for treatment breakthroughs: http://t.co/OJlMHUW
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence
medicalnewstoday.com — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that projected improvements in recurrence-free survival and an only modes” View full resource at medicalnewstoday.com
Most Recently Shared on December 9, 2010 at 6:05 pm By:
MNT Ovarian Cancer Health News
Drug-Treatment Opportunities In Advanced Ovarian Cancer Will Be Limited By A Reduced Risk Of Disease Recurrence http://mnt.to/3NP9
Ovarian Cancer Treatment - Ovarian Cancer and Treatment
ovariancancer.about.com — “Self education and asking focused questions about ovarian cancer will alert your physician that you have spent time trying to learn something about your situation. This should spark better, more in-depth, discussions about your ovarian cancer treatment options.” View full resource at ovariancancer.about.com
Most Recently Shared on January 6, 2010 at 9:59 pm By:
Pacific Oncology Physician Group
Ovarian Cancer: Asking the Right Questions About Ovarian Cancer: http://short.to/12lj5 #cancer via @jcchancellor
Bevacizumab extends progression-free survival in women with advanced ovarian cancer
news-medical.net — “Newly reported results from a major clinical trial show that adding bevacizumab (Avastin) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance dose of the drug afterwards significantly extends progression-free survival. Women receiving the new treatment regimen saw no worsening of their disease for 14.1 months, compared to 10.3 months for women receiving standard therapy.” View full resource at news-medical.net
Most Recently Shared on June 7, 2010 at 12:55 pm By:
Ovarian Cancer News: Bevacizumab extends progression-free survival in women with advanced ovarian cancer: Newly ... http://buzzup.com/zltp
MedWire News - Ob/Gyn - Advances made in personalized approach to ovarian cancer treatment
medwire-news.md — “MedWire News Research results show it is feasible to genotype ovarian cancer tissue and identify mutations that could be targeted with specific drugs, which could lead to a personalized approach to treatment. MedWire News” View full resource at medwire-news.md
Most Recently Shared on December 1, 2010 at 3:06 am By:
Advances made in personalized approach to ovarian cancer treatment: Research results show it is feasible to geno... http://bit.ly/eIlew3
Promising Treatment for Ovarian Cancer | Medical News and Health Information
ivanhoe.com — “(Ivanhoe Newswire) -- Adding Avastin (bevacizumab) to standard frontline chemotherapy for women with advanced ovarian cancer and then continuing a maintenance d” View full resource at ivanhoe.com
Most Recently Shared on June 8, 2010 at 6:41 pm By:
Promising Treatment for Ovarian Cancer: (Ivanhoe Newswire) -- Adding Avastin (bevacizumab) to standard frontline c... http://bit.ly/906KBR
Ovarian Cancer: eMedicine Oncology
emedicine.medscape.com — “Overview: Ovarian cancer is the most common cause of cancer death from gynecologic tumors in the United States. Early disease causes minimal, nonspecific, or no symptoms. Therefore, most cases are diagnosed in an advanced stage. Overall, prognosis ...” View full resource at emedicine.medscape.com
Most Recently Shared on April 12, 2010 at 6:04 pm By:
Medscape Oncology Health Site and Oncology
Ovarian Cancer: Study finds cytoreductive surgery safe and effective in platinum-sensitive recurrent ovarian cancer. http://bit.ly/9ZmUBA
EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment
medicalnewstoday.com — “EGEN, Inc. announced that the first Phase II clinical trial utilizing EGEN-001 for the treatment of recurrent ovarian cancer is now open for enrollment. The trial is sponsored by the Gynecologic” View full resource at medicalnewstoday.com
Most Recently Shared on December 15, 2010 at 6:05 pm By:
MNT Ovarian Cancer Health News
EGEN, Inc. Announces That Phase II Clinical Trial For Advanced Ovarian Cancer Is Open For Enrollment http://mnt.to/3P6r #ovariancancer
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Disabled World
Official Site - Disability News, Community, Videos. Article submissions welcome. Disability and Health RSS feeds for website content.
-
Ovarian Cancer OW
Organizing ovarian cancer resources shared by health experts, advocates, and organizations into WisdomCards.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement
